Fennec Pharmaceuticals is trading at $11.49, up +6.00%, with the move appearing aligned with biotech-sector strength.
- No company-specific announcement dated August 7, 2026 was identified; the latest company news scheduled second-quarter results for August 11, 2026.
- XBI rose 2.09%, alongside broader risk-on sentiment after weaker July employment data.
- Major indexes were higher as investors increased expectations for potential Federal Reserve rate cuts.